Related Experiment Video
Updated: Jul 18, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Increasing thyroid cancer incidence in Lithuania in 1978-2003
Giedre Smailyte1, Edita Miseikyte-Kaubriene, Juozas Kurtinaitis
1Institute of Oncology, Vilnius University, Division of Cancer Prevention, Polocko 2, Vilnius, Lithuania. gsmailyte@gmail.com
BMC Cancer
|December 13, 2006
Summary
Thyroid cancer incidence in Lithuania increased moderately from 1978-2000, then accelerated significantly by 2003. This rise in thyroid cancer is linked to improved diagnostic methods for thyroid nodules.
Area of Science:
- Epidemiology
- Oncology
- Public Health
Background:
- Analyzing thyroid cancer incidence trends in Lithuania from 1978-2003.
- Focusing on changes observed between 1993-2003.
Purpose of the Study:
- To analyze changes in thyroid cancer incidence trends in Lithuania.
- To identify significant shifts in these trends using joinpoint regression.
Main Methods:
- Utilized data from the Lithuanian Cancer Registry (1978-2003).
- Calculated age-specific and standardized incidence rates using the world standard population.
- Applied joinpoint regression to estimate annual percentage changes and detect trend shifts.
Main Results:
- Age-standardized incidence rates rose from 0.7 to 2.5 (males) and 1.5 to 11.4 (females) per 100,000.
- Joinpoint analysis revealed a trend shift in 2000, indicating a dramatic increase.
- Increases in papillary carcinoma and Stage I thyroid cancer drove recent trend changes.
Conclusions:
- Observed a moderate increase in thyroid cancer incidence (1978-2000).
- Documented an accelerated rise in incidence from 2000-2003.
- Attributed the increase to enhanced diagnosis of non-palpable thyroid nodules via ultrasound-guided fine needle aspiration biopsy.
Related Concept Videos
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...